| Metric | Value (₹ Cr) | vs Q3 FY25 |
|---|---|---|
| Revenue | 465.85 | 2.9% |
| Total Income | 470.46 | 2.7% |
| Expenditure | 444.75 | 5.2% |
| PBT | 25.71 | 27.0% |
| Net Profit | 20.32 | 23.9% |
| OPM | 9.07% | 3.86pp |
| NPM | 4.32% | 1.51pp |
| EPS | 0.35 | 28.6% |
Morepen Board Proposes Dividend After 23 Years, Scores Highest PAT of Rs. 118 in FY25
13 May 2025 · 13 May 2025, 09:19 am
Summary
Morepen Laboratories Ltd. board has proposed to declare a dividend (Rs.0.20 per share) after a gap of 23 years. The proposal comes on the back of excellent financial results for FY25, with gross revenue rising to ~1,830 crore, a 7.4% year-on-year increase. EBITDA surged 21.6% to ¥118 crore, and Profit After Tax jumped to ~118 crore, while Earnings Per Share (EPS) climbed to ¥2.20, up 17% from the previous year.
Key Highlights
- 1
Morepen board proposes dividend after 23 years
- 2
Gross revenue for FY25 increased by 7.4% to ~1,830 crore
- 3
EBITDA surged by 21.6% to ¥118 crore
- 4
Profit After Tax jumped to ~118 crore
- 5
Earnings Per Share (EPS) climbed to ¥2.20, up 17% from the previous year
- 6
Highest PAT of Rs. 118 in FY25
Management Comments
Sushil Suri
This moment is symbolic — it’s not just about distributing profits; it’s about rewarding trust. We always believe in the ‘Joy of Growing Together’. Declaring a dividend after 23 years reflects our financial strength, operational excellence, and long-term vision of sharing and caring. Our shareholders have stood by us, and it’s time we give back.
Informational and educational content only. Not investment advice.